Product Code: MDS095A
Highlights:
The global market for hemoglobin A1c testing devices and kits is estimated to increase from $2.1 billion in 2023 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.
The global market for chromatography segment of hemoglobin A1c testing devices and kits is estimated to increase from $940.6 million in 2023 to reach $1.4 billion by 2028, at a CAGR of 8.1% from 2023 through 2028.
The global market for assay techniques segment of hemoglobin A1c testing devices and kits is estimated to increase from $728.7 million in 2023 to reach $1.2 billion by 2028, at a CAGR of 9.8% from 2023 through 2028.
Report Scope:
This report aims to provide a comprehensive study of the global market for Hemoglobin A1c Testing Devices & Kits. It describes the different types of Hemoglobin A1c Testing Devices & Kits products, technology, and their current and historical market revenues.
This report discusses the implications of the trends mentioned above in the context of the current size and growth of the diabetes market, in global terms and by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the leading drug and device categories as well as breakdowns of the diabetes market by country.
Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for the Market for Hemoglobin A1c Testing Devices and Kits.
This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data is provided for 2022 as the base year, 2023, and forecast through year-end 2028.
Report Includes:
- 131 data tables and 46 additional tables
- An overview of the global market landscape related to the hemoglobin A1c testing devices and kits
- In-depth analysis of global market trends, featuring historical revenue data for 2020- 2022, estimated figures for 2023, as well as forecasts for 2023-2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to hemoglobin A1c testing devices and kits, accompanied by a comprehensive market share analysis categorized by technology, end user, and geographical region
- Understanding of the upcoming market potential for hemoglobin A1c test devices and kits, and areas of focus to forecast this market into various segments and sub-segments
- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, regulations, prospects, and contributions to the overall market
- Discussion of the role and importance of ESG in HbA1c test devices and kits market, consumer attitudes, risks and opportunity assessment, and ESG practices in the industry
- Identification of the major stakeholders and analysis of their company competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
- Detailed profiles of leading market participants including Abbott, Siemens Healthineers, Bayer AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories Inc., providing a descriptive overview of their respective businesses
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Methodology
- Secondary Research
- Primary Interviews
- Information Sources
- Geographic Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
Chapter 3 Market Overview
- Overview
- What is Diabetes?
- Types of Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes Mellitus (GDM) or Hyperglycemia in Pregnancy
- Impaired Glucose Tolerance (IGT) and Impaired Fasting Glucose (IFG)
- Epidemiology of Diabetes
- Gender Distribution
- Regional Disparities
- A1C Test
- Importance of A1C Test
- Diagnostic Potentials of HbA1c
- Certified A1C Test Devices
Chapter 4 Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Opportunities
Chapter 5 Global Market for Hemoglobin A1c Testing Devices and Kits by Technology
- Introduction
- Chromatography
- High-Performance Liquid Chromatography (HPLC)
- Cation-Exchange HPLC
- Boronate Affinity Chromatography
- Capillary Electrophoresis (CE)
- Assay Techniques
- Immunoassay
- Enzymatic Assay
Chapter 6 Global Market for Hemoglobin A1c Testing Devices and Kits by End User
- Overview
- Commercial Laboratories
- Point of Care Settings
- Benefits of POC Testing
- PoC Testing Applications
- Hospitals and Clinics
- Home Care Organizations
- Other POCS
Chapter 7 Global Market for Hemoglobin A1c Testing Devices and Kits by Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- Italy
- France
- United Kingdom
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- India
- Australia & New Zealand (ANZ)
- China
- Rest of Asia-Pacific
- Rest of World
- Brazil
- GCC Countries
- Other RoW Countries
Chapter 8 Sustainability in the Hemoglobin A1c Testing Devices and Kits Industry: An ESG Perspective
- Importance of ESG in Hemoglobin A1c Testing Devices and Kits Manufacturing Industry
- ESG Ratings and Metrics: Understanding the Data
- Future Trends
- ESG Practices in the Hemoglobin A1c Testing Devices and Kits Manufacturing Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Case Study
- BCC Research Viewpoint
Chapter 9 Emerging Technology in the Diabetes Diagnosis Industry: Qualitative Perspective
- Introduction
- Emerging Trends in the Diabetes Medical Devices Industry
- Developments in Hemoglobin A1c Testing Devices and Kits
Chapter 10 M&A and Venture Funding Outlook in the Market
Chapter 11 Competitive Landscape
Chapter 12 Company Profiles
- ABBOTT
- ARKRAY INC.
- BAYER AG
- BIO-RAD LABORATORIES INC.
- DANAHER
- EKF DIAGNOSTICS HOLDINGS PLC
- F. HOFFMANN-LA ROCHE AG
- LUMIRADX
- MERIL LIFE SCIENCES PRIVATE. LTD.
- OSANG HEALTHCARE CO. LTD.
- SIEMENS HEALTHCARE GMBH
- SINOCARE INC.
- THERMO FISHER SCIENTIFIC INC.
- TRINITY BIOTECH PLC
- WUXI BIOHERMES BIOMEDICAL TECHNOLOGY CO. LTD.
- XIAMEN BIOTIME BIOTECHNOLOGY CO. LTD.
Chapter 13 Appendix
- Government Regulatory Agencies and Professional Organizations